Evaluation
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
The activity presented balanced, evidence-based content free of commercial bias.
The presenter(s) used an effective teaching strategy.
The presentation slides / digital materials / resources and handouts were high quality.
The content was relevant to / useful for my professional practice.
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.
The overall quality of the educational activity was excellent.
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
Apply Defense Health Agency –Procedural Instruction (DHA-PI) 6025.29 requirements and updated 2021 Centers for Disease Control and Prevention (CDC)/U.S. Public Health Service (USPHS) Clinical Practice Guideline (CPG) recommendations.
Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for Pre-exposure prophylaxis (PrEP) initiation to reduce their risk of HIV acquisition.
Educate nurses about HIV PrEP medications, side effects, contraindications, and Food and Drug Administration (FDA)-approved regimens to maximize safe use.
Describe different tools Public Health nurses may use to improve clinical challenges that may present.
Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies.
Explain HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources.
Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior to make indicated changes in strategies and support patients’ long-term health.
*
*
*
*
*
*
*